Archive for March 2nd, 2012

Pipeline updates and trial initiations for ARQL NVAX DRRX NYMX AVII + FOLD offering

Mar 02, 2012 No Comments by

Amicus Therapeutics, Inc. (Nasdaq:FOLD) announced today the pricing of an underwritten offering of 10m shares of its common stock at a price of $5.70 per share with net proceeds of approximately $54m with an option to issue an additional 1.5m shares. AVI BioPharma, Inc. (NASDAQ: AVII) issued an update noting that it had completed dosing in its Phase 2b […]

Daily News Read more